Therefore, further studies are warranted to assess the applicability of using the expression of αT-catenin and plakophilin-2 to differentiate patients with non-ischemic cardiomyopathy rather than ARVC. The gene discussed is PKP2; the disease is arrhythmogenic right ventricular cardiomyopathy.